- Home
- ALHC vs PTCT Comparison
ALHC vs PTCT Comparison
Compare ALHC & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALHC
- PTCT
- Stock Information
- Founded
- ALHC 2013
- PTCT 1998
- Country
- ALHC United States
- PTCT United States
- Employees
- ALHC N/A
- PTCT N/A
- Industry
- ALHC Medical Specialities
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- ALHC Health Care
- PTCT Health Care
- Exchange
- ALHC Nasdaq
- PTCT Nasdaq
- Market Cap
- ALHC 3.7B
- PTCT 3.7B
- IPO Year
- ALHC 2021
- PTCT 2013
- Fundamental
- Price
- ALHC $13.96
- PTCT $50.34
- Analyst Decision
- ALHC Buy
- PTCT Buy
- Analyst Count
- ALHC 11
- PTCT 14
- Target Price
- ALHC $17.45
- PTCT $63.57
- AVG Volume (30 Days)
- ALHC 2.9M
- PTCT 939.9K
- Earning Date
- ALHC 07-31-2025
- PTCT 08-07-2025
- Dividend Yield
- ALHC N/A
- PTCT N/A
- EPS Growth
- ALHC N/A
- PTCT N/A
- EPS
- ALHC N/A
- PTCT 7.51
- Revenue
- ALHC $3,001,892,000.00
- PTCT $1,772,758,000.00
- Revenue This Year
- ALHC $43.37
- PTCT $121.50
- Revenue Next Year
- ALHC $26.55
- PTCT N/A
- P/E Ratio
- ALHC N/A
- PTCT $6.72
- Revenue Growth
- ALHC 49.12
- PTCT 91.12
- 52 Week Low
- ALHC $7.05
- PTCT $28.72
- 52 Week High
- ALHC $21.06
- PTCT $58.38
- Technical
- Relative Strength Index (RSI)
- ALHC 37.10
- PTCT 54.78
- Support Level
- ALHC $14.24
- PTCT $49.47
- Resistance Level
- ALHC $15.73
- PTCT $52.45
- Average True Range (ATR)
- ALHC 0.61
- PTCT 1.54
- MACD
- ALHC -0.03
- PTCT -0.09
- Stochastic Oscillator
- ALHC 13.24
- PTCT 49.17
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.